| Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma (NCT00994500) | National Cancer Institute (NCI) | 2009-08-01 |
| ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors (NCT00946335) | National Cancer Institute (NCI) | 2009-07-01 |
| Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment (NCT00929903) | National Cancer Institute (NCI) | 2009-06-01 |
| Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor (NCT00638898) | City of Hope Medical Center | 2007-02-26 |
| Sunitinib in Treating Young Patients With Refractory Solid Tumors (NCT00387920) | National Cancer Institute (NCI) | 2006-10-01 |
| Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma (NCT00363272) | National Cancer Institute (NCI) | 2006-06-01 |
| AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors (NCT00326664) | National Cancer Institute (NCI) | 2006-03-01 |
| Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors (NCT00281944) | National Cancer Institute (NCI) | 2005-09-01 |
| Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas (NCT00101270) | National Cancer Institute (NCI) | 2005-03-01 |
| Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors (NCT00100880) | National Cancer Institute (NCI) | 2004-11-01 |
| Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment (NCT00091182) | National Cancer Institute (NCI) | 2004-10-01 |
| Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors (NCT00919750) | Children's Oncology Group | 2004-02-16 |
| Cilengitide in Treating Children With Refractory Primary Brain Tumors (NCT00063973) | National Cancer Institute (NCI) | 2003-07-01 |
| Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors (NCT00052780) | National Cancer Institute (NCI) | 2002-10-01 |
| FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia (NCT00053963) | National Cancer Institute (NCI) | 2002-09-01 |
| Irinotecan in Treating Children With Refractory Solid Tumors (NCT00004078) | Children's Oncology Group | 1999-10-01 |